Prognosis is largely determined by the extent of pulmonary damage.
Antisynthetase syndrome
CREST syndrome
Mixed connective tissue disease
Anti-IgLON5 disease
TNF receptor associated periodic syndrome
Auto-brewery syndrome
Cryopyrin-associated periodic syndrome
Mast cell activation syndrome